• Adriano Chiò, Marco Pagani, Federica Agosta, Andrea Calvo, Angelina Cistaro, and Massimo Filippi.
• ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy. Electronic address: achio@usa.net.
• Lancet Neurol. 2014 Dec 1; 13 (12): 1228-40.

AbstractIn the past two decades, structural and functional neuroimaging findings have greatly modified longstanding notions regarding the pathophysiology of amyotrophic lateral sclerosis (ALS). Neuroimaging studies have shown that anatomical and functional lesions spread beyond precentral cortices and corticospinal tracts, to include the corpus callosum; frontal, sensory, and premotor cortices; thalamus; and midbrain. Both MRI and PET studies have shown early and diffuse loss of inhibitory cortical interneurons in the motor cortex (increased levels of functional connectivity and loss of GABAergic neurons, respectively) and diffuse gliosis in white-matter tracts. In ALS endophenotypes, neuroimaging has also shown a diverse spreading of lesions and a dissimilar impairment of functional and structural connections. A possible role of PET in the diagnosis of ALS has recently been proposed. However, most neuroimaging studies have pitfalls, such as a small number and poor clinical characterisation of patients, absence of adequate controls, and scarcity of longitudinal assessments. Studies involving international collaborations, standardised assessments, and large patient cohorts will overcome these shortcomings and provide further insight into the pathogenesis of ALS. Copyright © 2014 Elsevier Ltd. All rights reserved.

9 keywords...

hide…